Poly Medicure Limited will host an earnings conference call on Monday, August 10, 2026, at 4:00 PM IST to discuss its unaudited financial results for the first quarter ended June 30, 2026 (Q1FY27). The announcement, filed with the Bombay Stock Exchange and the National Stock Exchange of India Limited on August 5, 2026, informs investors and analysts that management will provide insights into the company’s performance for the period.

The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Avinash Chandra, Company Secretary, who holds Membership Number A32270. The notice serves as a formal intimation to the exchanges regarding the upcoming discussion on the company’s quarterly financial health.

Key Participants

The earnings call will be led by senior leadership from Poly Medicure Limited. The following executives are scheduled to participate in the session:

Call Details

Investors can join the conference call via a universal dial-in number or through a registration link provided in the company’s communication. The session is scheduled to run from 4:00 PM to 5:00 PM IST. For those requiring assistance, Apoorv Rastogi is listed as the coordinator, reachable via mobile or email as detailed in the official notice. The company has emphasized that all details regarding the link for joining and dial-in procedures are enclosed with the intimation.

Poly Medicure 's Managing Director has stated that the company is investing in new facilities and products with the objective of doubling its international sales. The announcement signals a deliberate strategic focus on global expansion, with the company channeling resources into both infrastructure and product development to support its international growth ambitions.

Strategic Investment in Facilities and Products

According to the Managing Director, Poly Medicure is directing investments toward new manufacturing facilities and an expanded product portfolio as part of its international growth strategy. The dual focus on capacity expansion and product innovation reflects the company's intent to strengthen its competitive positioning in global markets.

International Sales Growth Target

The MD's statement highlights the company's target to double its international sales, positioning global markets as a key growth driver. The investment in new facilities and products is being pursued as the primary lever to achieve this objective.

Key Highlights

• Poly Medicure's MD has outlined plans to double international sales
• Investments are being directed toward new manufacturing facilities
• New product development is a core component of the international expansion strategy

The Managing Director's statement underscores Poly Medicure's commitment to scaling its international business through targeted investments in infrastructure and product capabilities. The company's focus on doubling international sales reflects its broader ambition to grow its global market presence.